您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > AVG-233
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
AVG-233
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
AVG-233图片
CAS NO:2151937-80-1
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议

产品介绍
AVG-233 是一种口服有效的 RNA 依赖性 RNA 聚合酶 (RdRp) 抑制剂。AVG-233 阻止启动子上的病毒聚合酶复合物的启动。AVG-233 结合位点存在于 L1-1749片段中。AVG-233 对 RSV 毒株和临床分离株均具有纳摩尔活性 (EC50=0.14-0.31 μM)。AVG-233 可用于呼吸道合胞病毒 (RSV) 研究。
生物活性

AVG-233 is a potent, orally activeRNA dependent RNA polymerase (RdRp)inhibitor. AVG-233 prevents initiation of the viral polymerase complex at the promoter. AVG-233 binding site is present in the L1-1749fragment. AVG-233 has nanomolar activity against bothRSVstrains and clinicalRSVisolates (EC50=0.14-0.31 μM). AVG-233 can be used for research of respiratory syncytial virus (RSV)[1][2].

体外研究
(In Vitro)

AVG-233 (1-100 μM) blocks 3'RNA extension elongation but does not interfere with 3'RNA extension by up to three nucleotides after de novo initiation from the promoter or back-priming[1].
AVG-233 (20 μM) reduces virus yield of RSV A2-L19F (EC50=0.31 μM), RSV strain 2-20 (EC50=0.14 μM) and RSV clinical isolate 718 (EC50=0.2 μM)[1].
AVG-233 (1.25-40 μM; 0-300 s) suppresses RNA synthesis by the L1-1749fragment in a dose-dependent manner with an IC50value of 13.7 μM. AVG-233 bounds L and the L1-1749fragment with similar affinities (dissociation constants (KD’s) are 38.3 μM and 53.1 μM, respectively)[2].

体内研究
(In Vivo)

AVG-233 (50-100 mg/kg; i.g.; once) decreases lung viral load in the RSV mouse model[2].
AVG-233 (2-20 mg/kg; i.v. and p.o.; once; male CD-1 mice) has good orally bioavailable and the maximum plasma concentration about 2 μM[1].

Animal Model:Female Balb/cJ mice with recRSV-mKate xenograft[2]
Dosage:50 and 100 mg/kg
Administration:Oral gavage; once
Result:Reduced in lung viral load of 0.89 log10TCID50(median tissue culture infectious dose)/mL.
Animal Model:Male CD-1 mice (27-29 g)[1]
Dosage:2 mg/kg (i.v.) and 20 mg/kg (p.o.)
Administration:Intravenous injection and oral administration; once, obtains blood samples at pre-dose and 0.083, 0.25, 0.5, 1, 2, 4, 8, and 24 h post-dosing
Result:1.19
RouteDoseTmaxCmaxAUC0-∞CL/FT1/2Bioavailability
mg/kghnmol/mlh×nmol/mlliters/h/kgh%
Oral2012.175.956.985.2833.8
分子量

487.94

性状

Solid

Formula

C26H22ClN5O3

CAS 号

2151937-80-1

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)